{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:50:31Z","timestamp":1790419831965,"version":"4.1.0"},"reference-count":45,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Open Access Publication Fund of the University of Wuerzburg"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>(1) Background: The first-line treatment for patients with focal or segmental dystonia with a craniocervical distribution is still the intramuscular injection of botulinum neurotoxin (BoNT). However, some patients experience primary or secondary treatment failure from this potential immunogenic therapy. Deep brain stimulation (DBS) may then be used as a backup strategy in this situation. (2) Methods: Here, we reviewed the current study literature to answer a specific question regarding the efficacy and safety of the use of DBS, particularly for cervical dystonia (CD) and Meige syndrome (MS) in patients with documented treatment failure under BoNT. (3) Results: There are only two studies with the highest level of evidence in this area. Despite this clear limitation, in the context of the narrowly defined research question of this paper, it is possible to report 161 patients with CD or MS who were included in studies that were able to show a statistically significant reduction in dystonic symptoms using DBS. Safety and tolerability data appeared adequate. However, much of the information is based on retrospective observations. (4) Conclusions: The evidence base in this area is in need of further scientific investigation. Most importantly, more randomized, controlled and double-blind trials are needed, possibly including a head-to-head comparison of DBS and BoNT.<\/jats:p>","DOI":"10.3390\/toxins15100606","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T12:51:04Z","timestamp":1696855864000},"page":"606","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Deep Brain Stimulation for Focal or Segmental Craniocervical Dystonia in Patients Who Have Failed Botulinum Neurotoxin Therapy\u2014A Narrative Review of the Literature"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9042-7689","authenticated-orcid":false,"given":"Thorsten M.","family":"Odorfer","sequence":"first","affiliation":[{"name":"Department of Neurology, University Hospital W\u00fcrzburg, Josef-Schneider-Str. 11, 97080 W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Volkmann","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital W\u00fcrzburg, Josef-Schneider-Str. 11, 97080 W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: A consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov. Disord."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/WCO.0000000000000580","article-title":"Dystonia as a network disorder: A concept in evolution","volume":"31","author":"Schirinzi","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/brain\/awr224","article-title":"The non-motor syndrome of primary dystonia: Clinical and pathophysiological implications","volume":"135 Pt. 6","author":"Stamelou","year":"2012","journal-title":"Brain"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/jnnp-2020-325193","article-title":"Quality of life in isolated dystonia: Non-motor manifestations matter","volume":"92","author":"Junker","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/WCO.0000000000001165","article-title":"New developments in diagnostics and treatment of adult-onset focal dystonia","volume":"36","author":"Centen","year":"2023","journal-title":"Curr. Opin. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","article-title":"Double-blind study of botulinum toxin in spasmodic torticollis","volume":"2","author":"Tsui","year":"1986","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1136\/bmj.290.6485.1857","article-title":"Effect of treatment with botulinum toxin on neurogenic blepharospasm","volume":"290","author":"Elston","year":"1985","journal-title":"Br. Med. J. Clin. Res. Ed."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00702-021-02312-4","article-title":"Consensus guidelines for botulinum toxin therapy: General algorithms and dosing tables for dystonia and spasticity","volume":"128","author":"Dressler","year":"2021","journal-title":"J. Neural. Transm."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Erro, R., Picillo, M., Pellecchia, M.T., and Barone, P. (2023). Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review. Toxins, 15.","DOI":"10.3390\/toxins15060391"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.toxicon.2017.09.004","article-title":"Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?","volume":"147","author":"Jinnah","year":"2018","journal-title":"Toxicon"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s004150050345","article-title":"Long-term treatment of cervical dystonia with botulinum toxin A: Efficacy, safety, and antibody frequency. German Dystonia Study Group","volume":"246","author":"Kessler","year":"1999","journal-title":"J. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/PRS.0000000000008904","article-title":"Botulinum Toxin Type A Immunogenicity across Multiple Indications: An Overview Systematic Review","volume":"149","author":"Rahman","year":"2022","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bellows, S., and Jankovic, J. (2019). Immunogenicity Associated with Botulinum Toxin Treatment. Toxins, 11.","DOI":"10.3390\/toxins11090491"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1080\/14656566.2022.2147823","article-title":"An overview of the pharmacotherapeutics for dystonia: Advances over the past decade","volume":"23","year":"2022","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-1331.2010.03042.x","article-title":"EFNS guidelines on diagnosis and treatment of primary dystonias","volume":"18","author":"Albanese","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.brs.2022.08.025","article-title":"Restoration of functional network state towards more physiological condition as the correlate of clinical effects of pallidal deep brain stimulation in dystonia","volume":"15","author":"Filip","year":"2022","journal-title":"Brain Stimul."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S1474-4422(14)70143-7","article-title":"Pallidal neurostimulation in patients with medication-refractory cervical dystonia: A randomised, sham-controlled trial","volume":"13","author":"Volkmann","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMoa063618","article-title":"Pallidal deep-brain stimulation in primary generalized or segmental dystonia","volume":"355","author":"Kupsch","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa042187","article-title":"Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia","volume":"352","author":"Vidailhet","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_20","first-page":"CD012405","article-title":"Deep brain stimulation for dystonia","volume":"1","author":"Rodrigues","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_21","first-page":"445","article-title":"The Toronto Western Spasmodic Torticollis Rating Scale (TWSRTS): Assessment of validity and inter-rater reliability","volume":"40","author":"Consky","year":"1990","journal-title":"Neurology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1212\/WNL.35.1.73","article-title":"Validity and reliability of a rating scale for the primary torsion dystonias","volume":"35","author":"Burke","year":"1985","journal-title":"Neurology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"757579","DOI":"10.3389\/fnhum.2021.757579","article-title":"Deep Brain Stimulation Treating Dystonia: A Systematic Review of Targets, Body Distributions and Etiology Classifications","volume":"15","author":"Fan","year":"2021","journal-title":"Front. Hum. Neurosci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1007\/s00415-019-09462-2","article-title":"Deep brain stimulation for Meige syndrome: A meta-analysis with individual patient data","volume":"266","author":"Wang","year":"2019","journal-title":"J. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/ner.12345","article-title":"Deep Brain Stimulation for Craniocervical Dystonia (Meige Syndrome): A Report of Four Patients and a Literature-Based Analysis of Its Treatment Effects","volume":"19","author":"Wang","year":"2016","journal-title":"Neuromodulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/brain\/awm229","article-title":"The Canadian multicentre study of deep brain stimulation for cervical dystonia","volume":"130","author":"Kiss","year":"2007","journal-title":"Brain"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/mds.21580","article-title":"Pallidal deep brain stimulation in patients with cranial-cervical dystonia (Meige syndrome)","volume":"22","author":"Ostrem","year":"2007","journal-title":"Mov. Disord."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3171\/JNS\/2008\/109\/9\/0405","article-title":"A prospective blinded evaluation of deep brain stimulation for the treatment of secondary dystonia and primary torticollis syndromes","volume":"109","author":"Pretto","year":"2008","journal-title":"J. Neurosurg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3340\/jkns.2009.46.4.346","article-title":"Pallidal deep brain stimulation in primary cervical dystonia with phasic type: Clinical outcome and postoperative course","volume":"46","author":"Jeong","year":"2009","journal-title":"J. Korean Neurosurg. Soc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/mds.22686","article-title":"Pallidal stimulation for segmental dystonia: Long term follow up of 11 consecutive patients","volume":"24","author":"Sensi","year":"2009","journal-title":"Mov. Disord."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3340\/jkns.2010.48.2.134","article-title":"Outcome of pallidal deep brain stimulation in meige syndrome","volume":"48","author":"Ghang","year":"2010","journal-title":"J. Korean Neurosurg. Soc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1212\/WNL.0b013e31820f2e4f","article-title":"Subthalamic nucleus deep brain stimulation in primary cervical dystonia","volume":"76","author":"Ostrem","year":"2011","journal-title":"Neurology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/mds.23549","article-title":"Long-term clinical outcome in meige syndrome treated with internal pallidum deep brain stimulation","volume":"26","author":"Reese","year":"2011","journal-title":"Mov. Disord."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1468-1331.2011.03591.x","article-title":"Good long-term efficacy of pallidal stimulation in cervical dystonia: A prospective, observer-blinded study","volume":"19","author":"Skogseid","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3171\/2013.8.JNS13844","article-title":"A randomized double-blind crossover trial comparing subthalamic and pallidal deep brain stimulation for dystonia","volume":"119","author":"Schjerling","year":"2013","journal-title":"J. Neurosurg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.pjnns.2014.05.008","article-title":"Pallidal deep brain stimulation in the treatment of Meige syndrome","volume":"48","author":"Sobstyl","year":"2014","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3171\/2017.7.JNS17323","article-title":"Long-term outcome of pallidal stimulation for Meige syndrome","volume":"130","author":"Horisawa","year":"2018","journal-title":"J. Neurosurg."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.1038\/s41598-022-11841-1","article-title":"Bilateral subthalamic nucleus deep brain stimulation for refractory isolated cervical dystonia","volume":"12","author":"Yin","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJM199603283341306","article-title":"Assessment of quality-of-life outcomes","volume":"334","author":"Testa","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/jnnp.2003.013441","article-title":"Craniocervical dystonia questionnaire (CDQ-24): Development and validation of a disease-specific quality of life instrument","volume":"75","author":"Muller","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/mds.21481","article-title":"Thirty days complication rate following surgery performed for deep-brain-stimulation","volume":"22","author":"Voges","year":"2007","journal-title":"Mov. Disord."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e000881","DOI":"10.1136\/bmjopen-2012-000881","article-title":"Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: Results from an international observational study","volume":"2","author":"Misra","year":"2012","journal-title":"BMJ Open"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.parkreldis.2009.07.006","article-title":"Working capacity and cervical dystonia","volume":"16","author":"Martikainen","year":"2010","journal-title":"Park. Relat. Disord."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s42466-019-0007-3","article-title":"Pallidal neurostimulation versus botulinum toxin injections in the treatment of cervical dystonia: Protocol of a randomized, sham-controlled trial (StimTox-CD)","volume":"1","author":"Odorfer","year":"2019","journal-title":"Neurol. Res. Pract."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/15\/10\/606\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:03:51Z","timestamp":1760130231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/15\/10\/606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["toxins15100606"],"URL":"https:\/\/doi.org\/10.3390\/toxins15100606","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,9]]}}}